Clinical need for a nebulized corticosteroid

Journal of Allergy and Clinical Immunology

Volumn 104, Issue 4 SUPPL., 1999, Pages

  Szefler, Stanley J ^a,b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Asthma; Budesonide inhalation suspension; Infant; Inhaled corticosteroids; Nebulizer therapy; Pediatric

Indexed keywords

BUDESONIDE;

ANTIINFLAMMATORY ACTIVITY; ASTHMA; CHILD; CONFERENCE PAPER; CORTICOSTEROID THERAPY; DRUG EFFECT; DRUG FORMULATION; DRY POWDER; HOSPITALIZATION; HUMAN; INFANT; METERED DOSE INHALER; NEBULIZATION; PRACTICE GUIDELINE; PRIORITY JOURNAL;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ASTHMA; CHILD; CHILD, PRESCHOOL; HUMANS; NEBULIZERS AND VAPORIZERS;

EID: 0033501872     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(99)70057-6     Document Type: Article

References (58)

1. Kemper KJ. Chronic asthma: an update. Pediatr Rev 1996;17:111-7.
2. Centers for Disease Control and Prevention. Forecasted state-specific estimates of self-reported asthma prevalence: United States, 1998. MMWR 1998;47:1022-5.
3. Mannino DM, Homa DM, Pertowski CA, Ashizawa A, Nixon LL, Johnson CA, et al. Surveillance for asthma: United States, 1960-1995. MMWR 1998;47:l-28.
4. Yunginger JW, Reed CE, O'Connell EJ, Melton LJ III, O'Fallon WM, Silverstein MD. A community-based study of the epidemiology of asthma: incidence rates, 1964-1983. Am Rev Respir Dis 1992;148:888-94.
5. Centers for Disease Control and Prevention. Asthma mortality and hospitalization among children and young adults: United States, 1980-1993. MMWR 1996;45:350-3.
6. Åberg N, Hesselmar B, Åberg B, Eriksson B. Increase of asthma, allergic rhinitis and eczema in Swedish schoolchildren between 1979 and 1991. Clin Exp Allergy 1995;25:815-9.
7. Carman PG, Landau LI. Increased paediatric admissions with asthma in Western Australia: A problem of diagnosis? Med J Aust 1990;152:23-6.
8. Jackson RT, Mitchell EA. Trends in hospital admission rates and drug treatment of asthma in New Zealand. NZ Med J 1983;96:727-9.
9. Storr J, Barrell E, Lenney W. Rising asthma admissions and self referral. Arch Dis Child 1988;63:774-9.
10. Brown PJ, Greville HW, Finucane KE. Asthma and irreversible airflow obstruction. Thorax 1984;39:131-6.
11. Haahtela T. Airway remodeling takes place in asthma: What are the clinical implications? Clin Exp Allergy 1997;27:351-3.
12. Lemanske RF Jr, Busse WW. Asthma. JAMA 1997;278:1855-73.
13. National Asthma Education and Prevention Program. Expert panel report 2: guidelines for the diagnosis and management of asthma. Bethesda (MD): NIH/National Heart, Lung, and Blood Institute; 1997. Publication no. 97-4051.
14. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994;88:373-81.
15. Djukanovic R, Wilson JW, Britten KM, Wilson SJ, Walls AF, Roche WR, et al. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis 1992;145:669-74.
16. 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med 1991;325:388-92.
17. Haahtela T, Järvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 1994;331:700-5.
18. 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J Allergy Clin Immunol 1992;90:32-42.
19. Overbeek SE, Kerstjens HAM, Bogaard JM, Mulder PGH, Postma DS, the Dutch CNSLD Study Group. Is delayed introduction of inhaled corticosteroids harmful in patients with obstructive airways disease (asthma and COPD)? Chest 1996;110:35-41.
20. Szefler SJ. Leukotriene modifiers: What is their position in asthma therapy? J Allergy Clin Immunol 1998;102:170-2.
21. Szefler SJ, Nelson HS. Alternative agents for anti-inflammatory treatment of asthma. J Allergy Clin Immunol 1998;102(suppl):S23-S35.
22. Selroos O, Pietinalho A, Löfroos A-B, Riska H. Effect of early vs late intervention with inhaled corticosteroids in asthma. Chest 1995;108:1228-34.
23. Martinati LC, Boner AL. Clinical diagnosis of wheezing in early childhood. Allergy 1995;50:701-10.
24. Martinez ED, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ, et al. Asthma and wheezing in the first six years of life. N Engl J Med 1995;332:133-8.
25. Samet JM, Tager IB, Speizer FE. The relationship between respiratory illness in childhood and chronic air-flow obstruction in adulthood. Am Rev Respir Dis 1983;127:508-23.
26. Wright AL, Taussig LM, Ray CG, Harrison HR, Holberg CJ, the Group Health Medical Associates. The Tucson Children's Respiratory Study: II. Lower respiratory tract illness in the first year of life. Am J Epidemiol 1989;129:1232-46.
27. Godfrey S. Bronchiolitis and asthma in infancy and early childhood. Thorax 1996;51(suppl):S60-4.
28. Taussig LM. Wheezing in infancy: When is it asthma? Pediatr Pulmonol 1997;16(suppl):90-1.
29. Warner JO, Naspitz CK, Cropp GJA, eds. Third international pediatric consensus statement on the management of childhood asthma. Pediatr Pulmonol 1998;25:1-17.
30. Dodge R, Martinez ED, Cline MG, Lebowitz MD, Burrows B. Early childhood respiratory symptoms and the subsequent diagnosis of asthma. J Allergy Clin Immunol 1996;98:48-54.
31. Wainwright C, Isles AF, Francis PW. Asthma in children. Med J Austr 1997;167:218-23.
32. Delacourt C, Labbé D, Vassault A, Brunet-Langot D, de Blic J, Scheinmann P. Sensitization to inhalant allergens in wheezing infants is predictive of the development of infantile asthma. Allergy 1994;49:843-7.
33. Sporik R, Holgate ST, Platts-Mills TAE, Cogswell JJ. Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood: a prospective study. N Engl J Med 1990;323:502-7.
34. Reijonen TM, Korppi M. One-year follow-up of young children hospitalized for wheezing: the influence of early anti-inflammatory therapy and risk factors for subsequent wheezing and asthma. Pediatr Pulmonol 1998;26:113-9.
35. Ferguson AC, Whitelaw M, Brown H. Correlation of bronchial eosinophil and mast cell activation with bronchial hyperresponsiveness in children with asthma. J Allergy Clin Immunol 1992;90:609-13.
36. Koller DY, Wojnarowski C, Herkner KR, Weinländer G, Raderer M, Eichler I, et al. High levels of eosinophil cationic protein in wheezing infants predict the development of asthma. J Allergy Clin Immunol 1997;99:752-6.
37. Kristjánsson S, Strannegård I-L, Strannegård Ö, Peterson C, Enander I, Wennergren G. Urinary eosinophil protein X in children with atopic asthma: a useful marker of antiinflammatory treatment. J Allergy Clin Immunol 1996;97:1179-87.
38. Lødrup Carlsen KC, Halvorsen R, Ahlstedt S, Carlsen K-H. Eosinophil cationic protein and tidal flow volume loops in children 0-2 years of age. Eur Respir J 1995;8:1148-54.
39. Scher H, Berman D, Weinberg EG, Schinkel M, Peper B, Chalton DO, et al. Granulocyte proteins in serum in childhood asthma: relation to spirometry and therapy. Clin Exp Allergy 1996;26:1131-41.
40. Foucard T. Aggressive treatment of childhood asthma with local steroids. Good or bad? Allergy 1996;51:367-71.
41. Mueller GA, Eigen H. Pediatric pulmonary function testing in asthma. Pediatr Clin North Am 1992;39:1243-58.
42. Sly PD, Robertson CF. A review of pulmonary function testing in children. J Asthma 1990;27:137-47.
43. Calpin C, Macarthur C, Stephens D, Feldman W, Parkin PC. Effectiveness of prophylactic inhaled steroids in childhood asthma: a systematic review of the literature. J Allergy Clin Immunol 1997;100:452-7.
44. Wennergren G, Kristjánsson S, Strannegård I-L. Decrease in hospitalization for treatment of childhood asthma with increased use of antiinflammatory treatment, despite an increase in the prevalence of asthma. J Allergy Clin Immunol 1996;97:742-8.
45. Price JF, Weller PH. Comparison of fluticasone propionate and sodium cromoglycate for the treatment of childhood asthma (an open parallel group study). Respir Med 1995;89:363-8.
46. Edmunds AT, Goldberg RS, Duper B, Devichand P, Follows RMA, on behalf of the EMPHASIS research group. A comparison of budesonide 800 μg and 400 μg daily via Turbohaler with disodium cromoglycate via Spinhaler for asthma prophylaxis in children. Br J Clin Res 1994;5:11-23.
47. van Essen-Zandvliet EE, Hughes MD, Waalkens HJ, Duiverman EJ, Pocock SJ, Kerrebijn KF, et al. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. Am Rev Respir Dis 1992;146:547-54.
48. Verberne AAPH, Frost C, Roorda RJ, van der Laag H, Kerrebijn KF, the Dutch Paediatric Asthma Study Group. One year treatment with salmeterol compared with beclomethasone in children with asthma. Am J Respir Crit Care Med 1997;156:688-95.
49. Meltzer EO, Orgel HA, Ellis EF, Eigen HN, Hemstreet MPB. Long-term comparison of three combinations of albuterol, theophylline, and beclomethasone in children with chronic asthma. J Allergy Clin Immunol 1992;90:2-11.
50. Simons FER, the Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. N Engl J Med 1997;337:1659-65.
51. IMS Health National Disease and Therapeutic Index Audit, Year 1996 data.
52. IMS Health, Global Services Division. Midas International Prescription Database, Year 1996 data.
53. Blais L, Ernst P, Boivin J-F, Suissa S. Inhaled corticosteroids and the prevention of readmission to hospital for asthma. Am J Respir Crit Care Med 1998;158:126-32.
54. Clark TJH. Inhaled corticosteroids: first-line preventive therapy in asthma: evidence from the current medical literature [foreword], J Allergy Clin Immunol 1998;102(suppl):S2-S4.
55. Donahue JG, Weiss ST, Livingston JM, Goetsch MA, Greineder DK, Platt R. Inhaled steroids and the risk of hospitalization for asthma. JAMA 1997;277:887-91.
56. Agertoft L, Pedersen S. Influence of spacer device on drug delivery to young children with asthma. Arch Dis Child 1994;71:217-20.
57. Thorsson L, Edsbäcker S. Lung deposition of budesonide from a pressurized metered dose inhaler attached to a spacer. Eur Respir J 1998;12:1340-5.
58. Bush A. Asthma in the child under five. Br J Hosp Med 1996;55:110-4.